In high-risk patients, HCC screening protocols can lead to an earlier detection and at a treatable stage of the disease.
Keywords Multiparametric Magnetic Resonance Imaging, diagnosis, hepatocellular carcinoma Rezumat Carcinomul hepatocelular CHC este cea mai frecventă tumoră malignă primară a ficatului, asociată frecvent cu ciroza, cu o incidenţă crescândă la nivel mondial.
Protocoalele de screening al CHC la pacienţii cu risc crescut pot duce la detectarea mai precoce şi într-un stadiu tratabil al bolii.
Patients with haemochromatosis are at increased risk for HCC; obesity and diabetes associated with non-alcoholic steatohepatitis are other factors that may be associated with HCC 1. Imaging, in particular Multiparametric Magnetic Resonance Imaging MP MRI represents a key element in the diagnostic algorithm and in the multidisciplinary customized management of hepatic cancer ct patient, allowing the number and size of tumoral nodules, hepatic cancer ct semiology, the involvement of intra- and extrahepatic vascular structures portal venous structures — PV, hepatic veins — HV, inferior vena cava — IVCthe presence extrahepatic spread, the existence of anatomical variants or other incidentally discovered lesions In the giardia oameni contagioși time frame, until the hepatobiliary phase HBP is performed — 20 minutes after the i.
The hepatobiliary phase performed about 20 minutes after the i.
Figure 1. Figure 2. Other auxiliary criteria in favour of HCC are: identification of a non-enhancing capsule or pseudo-capsule in the periphery of nodules larger than 3 cm, visibility of the nodule on T2, T2 GRE and DWI wi, respectively hypointense round-oval lesion, on the ADC map 7,12,14,17tumor nodules with dimensions of more than 3 cm, having a mosaic-like pattern structure given by the presence of necrotic, haemorrhagic components, rarely lipomatous or intrinsic calcifications, which alternate with solid areas In the hepatobiliary phase, the vast majority of HCC nodules are T1 hypointense 7,8,14due to the anaplasia and the hepatocyte hepatic cancer ct into the tumor Figure 2.
Tumoral thrombosis presents an identical semiology to the hepatic tumor on unenhanced and enhanced MRI of the liver evaluationcharacteristic being the wash-in in AP and the wash-out in the PV or TP For lesions with dimensions equal to or greater than 2 cm, where there is a way of approach, a biopsy using ultrasound or CT guidance may be performed for histopathological framing 5,7,15, Figure 3. Table 1.
Differential diagnosis between benign and malignant hepatocellular nodules Conclusions The MP MRI with hepatospecific paramagnetic gadolinium-based contrast agent, centered on the abdomen, is the imaging modality of choice to evaluate liver cirrhotic nodules. The imaging report should contain a complete description of the hepatic nodule sof its complications portal thrombosis; metastasis-lymph nodes, pulmonary, bone disseminationanatomical variants, and other extrahepatic lesions discovered incidentally.
Conflict of interests: The author declares no conflict of interests. Hepatocellular carcinoma: a review.
Journal of Hepatocellular Carcinoma. MR imaging of hepatocellular Giardia ag ia in the cirrhotic liver: challenges and controversies.
Clasa Child A — scor 5 — 6 puncte ; supravietuirea este de 15 — 20 ani Clasa Child B — scor 7 — 9 puncte ; speranta de viata este de 4 — 14 ani Clasa Child C — scor 10 — 15 puncte ; speranta de viata este de 1 — 3 ani!!
Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I.
Development, growth, and spread: key pathologic and imaging aspects. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Eur Radiol. Extracellular contrast agent-enhanced MRI: min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with hepatic cancer ct liver disease.
Lupescu IG. Hepatic nodules in cirrhosis. A, Insight into Hepatic cancer ct. DOI Cannella R, Furlan A. Mosaic architecture of hepatocellular carcinoma.
Hepatic cancer diagnosis,
Abdom Radiol. Matteo Renzulli M, Brocchi S, et al.
Jun, Vol. Abstract: Neoadjuvant image-guided therapies comprises all locoregional treatment administred to hepatocellular caricinoma patients in order to maintain eligibility during liver hepatic cancer imaging waiting time: transcatheter arterial hepatic cancer imaging TACEselective internal radiation therapy SIRTchemical alcohol injection CAIradio frequency ablation RFA.
Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data - a pilot study.
MALIGNANT TUMORS OF DIGESTIVE ORGANS AND LIVER METASTASES AT THE TIME OF DIAGNOSIS
MRI for hepatocellular carcinoma: a primer for magnetic resonance imaging interpretation. Imaging findings of mimickers of hepatocellular carcinoma. Clin Mol Hepatol.
Pe de alta parte, cancerul hepatic secundar apare atunci cand o alta forma de cancer se metastaziaza. Spre exemplu, cancerul la plamani sau cel ovarian se pot raspandi la ficat.